GO45434 Phase II, Open-Label, Multicenter Study To Evaluate The Optimization Of The Cytokine Release Syndrome Profile For Glofitamab In Combination With Gemcitabine Plus Oxaliplatin In Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma



Mary Beth Wilwerding, RN Admin@NEcancertrials.com



Available at Nebraska Cancer Specialists, Omaha and Grand Island locations

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*

Email*

Phone*

Message*